Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-22-019458
Filing Date
2022-11-21
Accepted
2022-11-21 17:13:27
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rebusholdingsinc_10q.htm   iXBRL 10-Q 1145271
2 EXHIBIT 31.1 rebusholdingsinc_ex31-1.htm EX-31.1 11635
3 EXHIBIT 31.2 rebusholdingsinc_ex31-2.htm EX-31.2 11578
4 EXHIBIT 32.1 rebusholdingsinc_ex32-1.htm EX-32.1 8411
5 EXHIBIT 32.2 rebusholdingsinc_ex32-2.htm EX-32.2 8518
  Complete submission text file 0001829126-22-019458.txt   3914058

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rbsh-20220930.xsd EX-101.SCH 29196
7 XBRL CALCULATION FILE rbsh-20220930_cal.xml EX-101.CAL 35576
8 XBRL DEFINITION FILE rbsh-20220930_def.xml EX-101.DEF 99041
9 XBRL LABEL FILE rbsh-20220930_lab.xml EX-101.LAB 205831
10 XBRL PRESENTATION FILE rbsh-20220930_pre.xml EX-101.PRE 171400
47 EXTRACTED XBRL INSTANCE DOCUMENT rebusholdingsinc_10q_htm.xml XML 490389
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Rebus Holdings, Inc. (Filer) CIK: 0001421204 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 221406672
SIC: 2834 Pharmaceutical Preparations